B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells

References

• Batten M, Groom J, Cachero TG, et al. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 2000;192:1453–1466.
   PubMed Web of Science ®Google Scholar
• Yan M, Marsters SA, Grewal IS, et al. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity. Nat Immunol 2000;1:37–41.
   PubMed Web of Science ®Google Scholar
• Gross JA, Johnston J, Mudri S, et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 2000;404:995–999.
   PubMed Web of Science ®Google Scholar
• Thompson JS, Bixler SA, Qian F, et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 2001;293:2108–2111.
   PubMed Web of Science ®Google Scholar
• Darce JR, Arendt BK, Wu X, et al. Regulated expression of BAFF-binding receptors during human B cell differentiation. J Immunol 2007;179:7276–7286.
   PubMed Web of Science ®Google Scholar
• Chiu A, Xu W, He B, et al. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Blood 2007;109:729–739.
   PubMed Web of Science ®Google Scholar
• Pham LV, Fu L, Tamayo AT, et al. Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-kappaB-inducing kinase while activating both canonical and alternative nuclear factor-kappaB pathways. Blood 2011;117:200–210.
   PubMed Web of Science ®Google Scholar
• Briones J, Timmerman JM, Hilbert DM, et al. BLyS and BLyS receptor expression in non-Hodgkin's lymphoma. Exp Hematol 2002;30:135–141.
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Casola S, Kutok JL, et al. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 2004;173:2245–2252.
   PubMed Web of Science ®Google Scholar
• Shulga-Morskaya S, Dobles M, Walsh ME, et al. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol 2004;173:2331–2341.
   PubMed Web of Science ®Google Scholar
• Schiemann B, Gommerman JL, Vora K, et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001;293:2111–2114.
   PubMed Web of Science ®Google Scholar
• Warnatz K, Salzer U, Rizzi M, et al. B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci USA 2009;106:13945–13950.
   PubMed Web of Science ®Google Scholar
• Novak AJ, Slager SL, Fredericksen ZS, et al. Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma. Cancer Res 2009;69: 4217–4224.
   PubMed Web of Science ®Google Scholar
• Oki Y, Georgakis GV, Migone TS, et al. Elevated serum BLyS levels in patients with non-Hodgkin lymphoma. Leuk Lymphoma 2007;48:1869–1871.
   PubMed Web of Science ®Google Scholar
• Novak AJ, Grote DM, Ziesmer SC, et al. Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders. J Clin Oncol 2006;24:983–987.
   PubMed Web of Science ®Google Scholar
• Novak AJ, Grote DM, Stenson M, et al. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood 2004;104:2247–2253.
   PubMed Web of Science ®Google Scholar
• Hildebrand JM, Luo Z, Manske MK, et al. A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling. J Exp Med 2010;207: 2569–2579.
   PubMed Web of Science ®Google Scholar
• Lyu MA, Rai D, Ahn KS, et al. The rGel/BLyS fusion toxin inhibits diffuse large B-cell lymphoma growth in vitro and in vivo. Neoplasia 2010;12:366–375.
   PubMed Web of Science ®Google Scholar
• Kanakaraj P, Migone TS, Nardelli B, et al. BLyS binds to B cells with high affinity and induces activation of the transcription factors NF-kappaB and ELF-1. Cytokine 2001;13:25–31.
   PubMed Web of Science ®Google Scholar
• Claudio E, Brown K, Park S, et al. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 2002;3:958–965.
   PubMed Web of Science ®Google Scholar
• Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655–1657.
   PubMed Web of Science ®Google Scholar
• Patke A, Mecklenbrauker I, Erdjument-Bromage H, et al. BAFF controls B cell metabolic fitness through a PKC beta- and Akt-dependent mechanism. J Exp Med 2006;203:2551–2562.
   PubMed Web of Science ®Google Scholar
• Fasolo A, Sessa C. Targeting mTOR pathways in human malignancies. Curr Pharm Des 2012;18:2766–2777.
   PubMed Web of Science ®Google Scholar
• Parekh S, Weniger MA, Wiestner A. New molecular targets in mantle cell lymphoma. Semin Cancer Biol 2011;21:335–346.
   PubMed Web of Science ®Google Scholar
• Ghobrial IM, Zhang Y, Liu Y, et al. Targeting the bone marrow in Waldenstrom macroglobulinemia. Clin Lymphoma Myeloma Leuk 2011;11(Suppl. 1):S65–S69.
   Google Scholar
• Westendorf JJ, Ahmann GJ, Greipp PR, et al. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6. Leukemia 1996;10:866–876.
   PubMed Web of Science ®Google Scholar
• Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132:365–386.
   PubMedGoogle Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
   PubMed Web of Science ®Google Scholar
• Hatada EN, Do RK, Orlofsky A, et al. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells. J Immunol 2003;171:761–768.
   PubMed Web of Science ®Google Scholar
• Lu KP, Hanes SD, Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996;380:544–547.
   PubMed Web of Science ®Google Scholar
• Liao Y, Hung MC. Physiological regulation of Akt activity and stability. Am J Transl Res 2010;2:19–42.
   PubMed Web of Science ®Google Scholar
• Benson RJ, Hostager BS, Bishop GA. Rapid CD40-mediated rescue from CD95-induced apoptosis requires TNFR-associated factor-6 and PI3K. Eur J Immunol 2006;36:2535–2543.
   PubMed Web of Science ®Google Scholar
• Hildebrand JM, Luo Z, Manske MK, et al. A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling. J Exp Med 2010;207: 2569–2579.
   PubMed Web of Science ®Google Scholar
• Gupta M, Dillon SR, Ziesmer SC, et al. A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation. Blood 2009;113: 5206–5216.
   PubMed Web of Science ®Google Scholar
• Novak AJ, Darce JR, Arendt BK, et al. Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood 2004;103:689–694.
   PubMed Web of Science ®Google Scholar
• Moreaux J, Legouffe E, Jourdan E, et al. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 2004;103:3148–3157.
   PubMed Web of Science ®Google Scholar
• Maia S, Pelletier M, Ding J, et al. Aberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survival. PLoS One 2011;6:e20787.
   PubMed Web of Science ®Google Scholar
• Henley T, Kovesdi D, Turner M. B-cell responses to B-cell activation factor of the TNF family (BAFF) are impaired in the absence of PI3K delta. Eur J Immunol 2008;38:3543–3548.
   PubMed Web of Science ®Google Scholar
• So L, Yea SS, Oak JS, et al. Selective inhibition of phosphoinositide 3-kinase p110alpha preserves lymphocyte function. J Biol Chem 2013;288:5718–5731.
   PubMedGoogle Scholar
• Otipoby KL, Sasaki Y, Schmidt-Supprian M, et al. BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells. Proc Natl Acad Sci USA 2008;105:12435–12438.
   PubMed Web of Science ®Google Scholar
• Sarbassov DD, Ali SM, Kim DH, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004;14:1296–1302.
   PubMed Web of Science ®Google Scholar
• Do RK, Hatada E, Lee H, et al. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med 2000;192:953–964.
   PubMed Web of Science ®Google Scholar
• Craxton A, Draves KE, Gruppi A, et al. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J Exp Med 2005;202:1363–1374.
   PubMed Web of Science ®Google Scholar
• Ryo A, Suizu F, Yoshida Y, et al. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 2003;12:1413–1426.
   PubMed Web of Science ®Google Scholar
• Fan G, Fan Y, Gupta N, et al. Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family. Cancer Res 2009;69:4589–4597.
   PubMed Web of Science ®Google Scholar
• Lee TH, Pastorino L, Lu KP. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Expert Rev Mol Med 2011;13:e21.
   PubMed Web of Science ®Google Scholar
• Groom JR, Fletcher CA, Walters SN, et al. BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med 2007;204:1959–1971.
   PubMed Web of Science ®Google Scholar
• Treml LS, Carlesso G, Hoek KL, et al. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells. J Immunol 2007;178:7531–7539.
   PubMed Web of Science ®Google Scholar
• He B, Santamaria R, Xu W, et al. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol 2010;11:836–845.
   PubMed Web of Science ®Google Scholar
• Tun-Kyi A, Finn G, Greenwood A, et al. Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity. Nat Immunol 2011;12:733–741.
   PubMed Web of Science ®Google Scholar
• Woodland RT, Fox CJ, Schmidt MR, et al. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival. Blood 2008;111:750–760.
   PubMed Web of Science ®Google Scholar
• Spender LC, Inman GJ. Phosphoinositide 3-kinase/AKT/mTORC1/2 signaling determines sensitivity of Burkitt's lymphoma cells to BH3 mimetics. Mol Cancer Res 2012;10:347–359.
   PubMed Web of Science ®Google Scholar
• Qian J, Zou Y, Rahman JS, et al. Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung. Mol Cancer Ther 2009;8:101–109.
   PubMed Web of Science ®Google Scholar
• You H, Zheng H, Murray SA, et al. IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry. J Cell Biochem 2002;84:211–216.
   PubMed Web of Science ®Google Scholar
• Lee KY, Lee JW, Nam HJ, et al. PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells. Mol Cells 2011;32:107–111.
   PubMed Web of Science ®Google Scholar
• Hacker H, Vabulas RM, Takeuchi O, et al. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J Exp Med 2000;192:595–600.
   PubMed Web of Science ®Google Scholar
• Wang Q, Dziarski R, Kirschning CJ, et al. Micrococci and peptidoglycan activate TLR2--> MyD88--> IRAK--> TRAF--> NIK--> IKK--> NF-kappaB signal transduction pathway that induces transcription of interleukin-8. Infect Immun 2001;69:2270–2276.
   PubMed Web of Science ®Google Scholar
• Ishida T, Mizushima S, Azuma S, et al. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J Biol Chem 1996;271:28745–28748.
   PubMed Web of Science ®Google Scholar
• Rothe M, Sarma V, Dixit VM, et al. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 1995;269:1424–1427.
   PubMed Web of Science ®Google Scholar
• Xia XZ, Treanor J, Senaldi G, et al. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med 2000;192:137–143.
   PubMed Web of Science ®Google Scholar
• Hatzoglou A, Roussel J, Bourgeade MF, et al. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J Immunol 2000;165:1322–1330.
   PubMed Web of Science ®Google Scholar
• Xu LG, Shu HB. TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kappa B activation and IL-10 production. J Immunol 2002;169:6883–6889.
   PubMed Web of Science ®Google Scholar
• Vallabhapurapu S, Matsuzawa A, Zhang W, et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling. Nat Immunol 2008;9:1364–1370.
   PubMed Web of Science ®Google Scholar
• Yang WL, Wang J, Chan CH, et al. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 2009;325:1134–1138.
   PubMed Web of Science ®Google Scholar